Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in

被引:0
|
作者
Kuo, Li-Kuo [1 ,2 ]
Chang, Hou-Tai [3 ,4 ]
Hsueh, Shun-Chung [5 ]
Liu, Min [6 ]
Hsieh, Po-Chuen [6 ]
Jean, Shio-Shin [6 ,7 ,8 ]
机构
[1] Mackay Med Coll, Dept Med, New Taipei, Taiwan
[2] Mackay Mem Hosp, Dept Crit Care Med, Taipei, Taiwan
[3] Far Eastern Mem Hosp, Dept Crit Care Med, New Taipei, Taiwan
[4] Yuan Ze Univ, Dept Ind Engn & Management, Taoyuan, Taiwan
[5] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei, Taiwan
[6] Tajen Univ, Coll Pharm & Hlth Care, Dept Pharm, Pingtung 90741, Taiwan
[7] Min Sheng Gen Hosp, Dept Internal Med, 168 Ching Kuo Rd, Taoyuan 330, Taiwan
[8] Min Sheng Gen Hosp, Dept Crit Care Med, 168 Ching Kuo Rd, Taoyuan 330, Taiwan
关键词
Healthcare- associated pneumonia; Multidrug-resistant; Klebsiella pneumoniae; Acinetobacter baumannii complex; Pseudomonas aeruginosa; PSEUDOMONAS-AERUGINOSA; INFECTIONS;
D O I
10.1016/j.jmii.2024.07.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To understand the microbial profile and investigate the independent predictors for healthcare-associated pneumonia (HCAP) pertinaciously caused by isolates of multidrug-resistant (MDR) Gram-negative bacteria (GNB). Methods: Multicenter ICU patients who received appropriate antibiotic treatments for preceding pneumonia due to MDR GNB isolates and subsequently developed HCAP caused by either MDR GNB (n = 126) or non-MDR GNB (n = 40) isolates in Taiwan between 2018 and 2023 were enrolled. Between the groups of patients with HCAP due to MDR GNB and non-MDR GNB, the proportions of the following variables, including demographic characteristics, important co- morbidities, nursing home residence, physiological severity, intervals between two hospitalizations, steroid use, the tracheostomy tube use alone, ventilator support, and the predominant GNB species involving HCAP, were analyzed using the chi-square test. Logistic regression was employed to explore the independent predictors for HCAP persistently caused by MDR GNB in the aforementioned variables with a P-value of <0.15 in the univariate analysis. Results: MDR-Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex were the three predominant species causing HCAP. Chronic structural lung disorders, diabetes mellitus, intervals of <30 days between two hospitalizations, use of the tracheostomy tube alone, and prior pneumonia caused by MDR A. baumannii complex were shown to independently predict the HCAP tenaciously caused by MDR GNB. Conversely, the preceding pneumonia caused by MDR P. aeruginosa was a negative predictor. Conclusion: Identifying predictors for HCAP persistently caused by MDR GNB is crucial for prescribing appropriate antibiotics. Copyright <feminine ordinal indicator> 2024, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
引用
收藏
页码:801 / 811
页数:11
相关论文
共 50 条
  • [41] Moroccan Hospital Cockroaches: Carriers of Multidrug-Resistant Gram-Negative Bacteria
    Dihmane, Asmaa
    Aniba, Rafik
    Raqraq, Habiba
    Ressmi, Amina
    Chouati, Taha
    Abi, Oussama
    El Fahime, El Mostafa
    Nayme, Kaotar
    Timinouni, Mohammed
    Barguigua, Abouddihaj
    ECOHEALTH, 2025,
  • [42] An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria
    Cilloniz, Catia
    Dominedo, Cristina
    Torres, Antoni
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 656 - 662
  • [43] Multidrug-Resistant Gram-Negative Bacteria Infection Prevention and Control Update
    Mills, John P.
    Marchaim, Dror
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2021, 35 (04) : 969 - 994
  • [44] Ceftazidime-avibactam in the treatment of multidrug-resistant Gram-negative bacteria
    不详
    LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 646 - 647
  • [45] Multidrug-resistant Gram-negative bacteria: how to treat and for how long
    Giamarellou, Helen
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 : S50 - S54
  • [46] Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
    Jean, Shio-Shin
    Hsueh, Shun-Chung
    Lee, Wen-Sen
    Hsueh, Po-Ren
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (05) : 307 - 309
  • [47] Assessment of Colistin Treatment in Multidrug-Resistant Gram-Negative Bacterial Infections
    Coskun, Belgin
    Azap, Alpay
    Yilmaz, Gulden
    Ayhan, Muge
    Saricaoglu, Elif Mukime
    KLIMIK JOURNAL, 2020, 33 (02) : 142 - 147
  • [48] Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge?
    Curcio, Daniel
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (01): : 27 - 38
  • [49] State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms
    Yassin, Arsheena
    Huralska, Mariya
    Pogue, Jason M.
    Dixit, Deepali
    Sawyer, Robert G.
    Kaye, Keith S.
    CLINICAL INFECTIOUS DISEASES, 2023, : E46 - E56
  • [50] Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana
    Nicholas Agyepong
    Usha Govinden
    Alex Owusu-Ofori
    Sabiha Yusuf Essack
    Antimicrobial Resistance & Infection Control, 7